Your browser doesn't support javascript.
loading
A carbon monoxide releasing metal organic framework nanoplatform for synergistic treatment of triple-negative breast tumors.
Cong, Yiyang; Sun, Bo; Hu, Jianlun; Li, Xiaoyang; Wang, Yanan; Zhang, Jingyi; Yang, Dongzhi; Lu, Weifei; Ding, Zhi; Wang, Xiaofeng; Hong, Hao.
Affiliation
  • Cong Y; State Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210093, China.
  • Sun B; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China.
  • Hu J; State Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210093, China.
  • Li X; State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, 210093, China.
  • Wang Y; College of Veterinary Medicine, Henan Agriculture University, Zhengzhou, 450002, Henan, China.
  • Zhang J; College of Veterinary Medicine, Henan Agriculture University, Zhengzhou, 450002, Henan, China.
  • Yang D; Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, 221004, Jiangsu, China. dongzhiy@xzhmu.edu.cn.
  • Lu W; College of Veterinary Medicine, Henan Agriculture University, Zhengzhou, 450002, Henan, China.
  • Ding Z; State Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences, Nanjing University, 163 Xianlin Avenue, Nanjing, 210093, China. dingzhi@nju.edu.cn.
  • Wang X; Nanjing Key Laboratory of Advanced Functional Materials, Nanjing Xiaozhuang University, Nanjing, 211171, People's Republic of China.
  • Hong H; State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, 210093, China. haohong@nju.edu.cn.
J Nanobiotechnology ; 20(1): 494, 2022 Nov 24.
Article in En | MEDLINE | ID: mdl-36424645

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ruthenium / Triple Negative Breast Neoplasms / Metal-Organic Frameworks Limits: Humans Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ruthenium / Triple Negative Breast Neoplasms / Metal-Organic Frameworks Limits: Humans Language: En Journal: J Nanobiotechnology Year: 2022 Document type: Article